drugset / Trial / NCT05667038

Effect of Probiotics Among Overweight and Obese Saudi Adults

NCT05667038 ↗

Phase 3 Completed 90 enrolled King Saud University
RandomizedParallel-groupDouble-blindTreatment

Summary

Obesity is classified as a low-grade chronic and systemic inflammatory disease and results from complicated interactions between genes and environmental factors, which leads to many diseases and affects the quality of life. There are growing interests in the effectiveness of probiotics as a supplementation to treat obesity through regulating microbiota host metabolism. Probiotics may influence the interplays among gut, brain, adipose, and liver in a way leading to weight. Since limited studies have been conducted on human subjects, more investigation is needed in this field. Therefore, this study sheds light on the investigation of the anti-obesity effect of probiotic supplementation.

Timeline

Start
2022-03-03
Primary completion
2023-08-03
Completion
2023-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hexbio Unknown 3 g Oral

Indications